{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:37:27Z","timestamp":1753879047503,"version":"3.41.2"},"reference-count":31,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Obstet and Gynaecol"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>This study evaluates clinicopathological outcomes and clinicians' awareness regarding the management of atypical glandular cells (AGC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We analyzed 98 AGC cases, excluding known endometrial cancer, from 238 initial cases, with a median age of 42\u2009years (range 20\u201382). Cytological findings, including NOS and FN subcategories, diagnostic tests, treatments, and outcomes were evaluated. A survey on AGC awareness and practices was conducted among 134 obstetrician\u2010gynecologists.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 98 cases (AGC\u2010FN: 19.8%, AGC\u2010NOS: 13.2%, unspecified: 67.3%), 44.9% initially showed no neoplasia; this dropped to 38.8% following up, identifying 11 additional AIS or cervical adenocarcinomas. Overall, 28.5% had AIS or more, 18% had CIN, and 13.3% had other malignancies, indicating some over\/underdiagnosis. HPV testing in 79 cases showed a 48.1% positivity rate, including 14 type\u201018 and 12 type\u201016 cases. Among clinicians surveyed, 25% were aware of AGC subcategories, and only 11.9% were well\u2010versed. Approximately 65% associated AGC with malignancy or precancerous lesions, and 52.6% used multiple diagnostic methods simultaneously. Even in the absence of neoplasia, 80% continued cytological examinations every 3\u20134\u2009months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study underscores the challenges in AGC management, highlighting the importance of follow\u2010up and collaboration between clinicians and cytopathologists to detect significant lesions. It also emphasizes the need for providing learning opportunities for clinicians to address over\/undertreatment.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jog.16269","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T23:23:47Z","timestamp":1742340227000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Challenges in managing atypical glandular cells in cervical smears: Insights from real\u2010world data and clinicians' perspectives"],"prefix":"10.1111","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3151-8315","authenticated-orcid":false,"given":"Mika","family":"Mizuno","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine Kagoshima University  Kagoshima Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Nakazono","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine Kagoshima University  Kagoshima Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Furuzono","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine Kagoshima University  Kagoshima Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine Kagoshima University  Kagoshima Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine Kagoshima University  Kagoshima Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1920-9405","authenticated-orcid":false,"given":"Shinichi","family":"Togami","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine Kagoshima University  Kagoshima Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2491-2189","authenticated-orcid":false,"given":"Hiroaki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine Kagoshima University  Kagoshima Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.16.2114"},{"key":"e_1_2_9_3_1","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-11074-5","volume-title":"The Bethesda system for reporting cervical cytology: definitions, criteria, and explanatory notes","author":"Nayar R","year":"2015"},{"issue":"2","key":"e_1_2_9_4_1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk\u2010based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins RB","year":"2020","journal-title":"J Low Genit Tract Dis"},{"issue":"3","key":"e_1_2_9_5_1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.6004\/jnccn.2014.0035","article-title":"Cervical cancer screening","volume":"12","author":"Partridge EE","year":"2014","journal-title":"J Natl Compr Cancer Netw"},{"issue":"5","key":"e_1_2_9_6_1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad LS","year":"2013","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"e_1_2_9_7_1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/LGT.0000000000000628","article-title":"Erratum: 2019 ASCCP risk\u2010based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"25","author":"Perkins RB","year":"2021","journal-title":"J Low Genit Tract Dis"},{"issue":"3","key":"e_1_2_9_8_1","first-page":"403","article-title":"Analysis of atypical glandular cells in ThinPrep pap smear and follow\u2010up histopathology","volume":"37","author":"Wang T","year":"2024","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"4","key":"e_1_2_9_9_1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/cyt.13383","article-title":"Atypical glandular cells and predictive features of malignancy in pap smears: a retrospective monocentric study","volume":"35","author":"Cianfrini F","year":"2024","journal-title":"Cytopathology"},{"issue":"3","key":"e_1_2_9_10_1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cyt.12957","article-title":"Atypical glandular cells in Papanicolaou test: which is more important in the detection of malignancy, architectural or nuclear features?","volume":"32","author":"Polat AY","year":"2021","journal-title":"Cytopathology"},{"issue":"5","key":"e_1_2_9_11_1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000498977","article-title":"Clinicopathological characteristics of atypical glandular cells determined by cervical cytology in Japan: survey of gynecologic oncology data from the obstetrical gynecological society of Kinki district, Japan","volume":"63","author":"Toyoda S","year":"2019","journal-title":"Acta Cytol"},{"issue":"1","key":"e_1_2_9_12_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jasc.2017.08.001","article-title":"Cytologic parameters predicting neoplasia in Papanicolaou smears with atypical glandular cells and histologic follow\u2010up: a single\u2010institution experience","volume":"7","author":"Reynolds JP","year":"2018","journal-title":"J Am Soc Cytopathol"},{"issue":"3","key":"e_1_2_9_13_1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000471916","article-title":"The significance of glandular cells on conventional Cervicovaginal smears: experience from a tertiary Care Hospital in Coastal India","volume":"61","author":"Suresh PK","year":"2017","journal-title":"Acta Cytol"},{"issue":"2","key":"e_1_2_9_14_1","first-page":"234","article-title":"Atypical glandular cells and cervical cancer: systematic review","volume":"57","author":"Marques JP","year":"2011","journal-title":"Rev Assoc Med Bras"},{"volume-title":"Guidelines for Obstetrics and Gynecology Practice: Gynecological Outpatient Edition 2023","year":"2023","author":"Japan Society of Obstetrics and Gynecology (JSOG)","key":"e_1_2_9_15_1"},{"issue":"2","key":"e_1_2_9_16_1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cncy.22780","article-title":"Correlation of immediate prevalence of cervical precancers and cancers with HPV genotype and age in women with atypical glandular cells cytology: a retrospective analysis of 369 cases","volume":"132","author":"Zhou X","year":"2024","journal-title":"Cancer Cytopathol"},{"issue":"4","key":"e_1_2_9_17_1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/JOC.JOC_209_16","article-title":"Histological follow\u2010up in patients with atypical glandular cells on pap smears","volume":"34","author":"Boyraz G","year":"2017","journal-title":"J Cytol"},{"issue":"4","key":"e_1_2_9_18_1","first-page":"518","article-title":"Cytologic and histologic review of atypical glandular cells (AGC) detected during cervical cytology screening","volume":"13","author":"Jeng CJ","year":"2003","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"e_1_2_9_19_1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijgo.2012.05.027","article-title":"Factors predicting pathologic significance among women with atypical glandular cells on liquid\u2010based cytology","volume":"119","author":"Chatchotikawong U","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"e_1_2_9_20_1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/dc.23452","article-title":"Glandular epithelial abnormalities on thinprep\u00ae pap tests: clinical and cytohistologic correlation","volume":"44","author":"Selvaggi SM","year":"2016","journal-title":"Diagn Cytopathol"},{"issue":"4","key":"e_1_2_9_21_1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2303.2004.00163.x","article-title":"A retrospective clinical audit of cervical smears reported as \u2018glandular neoplasia\u2019","volume":"15","author":"Kirwan JM","year":"2004","journal-title":"Cytopathology"},{"issue":"2","key":"e_1_2_9_22_1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/joc.joc_172_23","article-title":"Cytologic parameters in predicting the outcome of atypical glandular cells on Papanicolaou smears: a single\u2010institutional experience","volume":"41","author":"Phalak PA","year":"2024","journal-title":"J Cytol"},{"issue":"8","key":"e_1_2_9_23_1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncy.21724","article-title":"Clinical significance of atypical glandular cells in pap tests: an analysis of more than 3000 cases at a large academic women's center","volume":"124","author":"Pradhan D","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1159\/000325117"},{"issue":"5","key":"e_1_2_9_25_1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/dc.10316","article-title":"Atypical glandular cells\u2014an update","volume":"29","author":"Cangiarella JF","year":"2003","journal-title":"Diagn Cytopathol"},{"issue":"3","key":"e_1_2_9_26_1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jasc.2024.01.004","article-title":"Atypical glandular cells in pap tests: cytology\u2010histology correlation and risk assessment with human papillopmavirus (HPV) testing","volume":"13","author":"Goetz LH","year":"2024","journal-title":"J Am Soc Cytopathol"},{"issue":"11","key":"e_1_2_9_27_1","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/ijc.34242","article-title":"Atypical glandular cells and development of cervical cancer: population\u2010based cohort study","volume":"151","author":"Norman I","year":"2022","journal-title":"Int J Cancer"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602915"},{"key":"e_1_2_9_29_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000541641","article-title":"The utility of an human papillomavirus genotype assay for cancer screening in self\u2010collected urine and vaginal samples from Japanese women","volume":"1","author":"Mizuno M","year":"2024","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"e_1_2_9_30_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2018.7464","article-title":"Effect of screening with primary cervical HPV testing vs cytology testing on high\u2010grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial","volume":"320","author":"Ogilvie GS","year":"2018","journal-title":"JAMA"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20076"},{"issue":"6","key":"e_1_2_9_32_1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2303.2012.00981.x","article-title":"Diagnostic and therapeutic dilemma associated with atypical glandular cells on liquid\u2010based cervical cytology","volume":"23","author":"Chummun K","year":"2012","journal-title":"Cytopathology"}],"container-title":["Journal of Obstetrics and Gynaecology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jog.16269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T11:18:18Z","timestamp":1743333498000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/jog.16269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1111\/jog.16269"],"URL":"https:\/\/doi.org\/10.1111\/jog.16269","archive":["Portico"],"relation":{},"ISSN":["1341-8076","1447-0756"],"issn-type":[{"type":"print","value":"1341-8076"},{"type":"electronic","value":"1447-0756"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2025-01-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e16269"}}